Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Oxford Gene Technology
Oxford Gene Technology
Activities:
Regulatory
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Pharmaceutical
Cytocell operations move to Cambridge Science Park
Growth of the Oxford Gene Technology's brand has lead to an investment in expanding the production capacity to meet demand
Regulatory
Oxford Gene Technology announces organisational changes
Analysis
OGT pushes forward hybridisation-based targeted sequencing
OGT’s hybridisation expertise takes researchers from sample to sequencer in a single day
Analysis
OGT expands Cytocell sarcoma FISH probe range
Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its range of Cytocell Aquarius fluorescence in situ hybridisation (FISH) probes for pathology
Research & Development
Oxford Gene Technology to purchase Cytocell
Underscores commitment to become a global leader in genomic medicine
Pharmaceutical
OGT develops biomarker panel to support earlier SLE diagnosis
The panel is said to have superior sensitivity and specificity compared to current laboratory tests
Research & Development
OGT expands commitment to improved cancer profiling with CCMC agreement
Will design a whole genome, cancer-specific microarray
Subscribe now